• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Drugmaker Apotex accuses Amarin of Vascepa monopoly in US lawsuit

    REUTERS

    Apotex Launches Generic Fertility Treatment Cetrorelix In US

    PR NEWSWIRE

    U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents

    REUTERS

    Enforcement Report - Week of February 28, 2024

    FDA

    Apotex`s Generic Apixaban Receives Approval in the U.S.

    FDA

    Apotex`s Generic Macitentan Receives Approval in the U.S.

    FDA

    Apotex`s Generic Nilotinib Hydrochloride Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of December 6, 2023

    FDA

    Apotex`s Generic Teriparatide Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of June 14, 2023

    FDA

    Enforcement Report - Week of May 17, 2023

    FDA

    Enforcement Report - Week of March 15, 2023

    FDA

    Apotex Corp. Issues Voluntary Nationwide Recall of Brimonidine Tartrate Ophthalmic Solution

    FDA

    Health Canada Issues Recall of Apotex`s APO-AMITRIPTYLINE 10mg: NDMA Impurity

    HEALTH CANADA

    Apotex`s Generic Cyclosporine A Receives Approval in the U.S.

    FDA

    Jazz sues generics for infringement on cannabis-derived drug

    FIERCE PHARMA

    Enforcement Report - Week of January 4, 2023

    FDA

    Health Canada Issues Recall of Apotex`s Apo-Acyclovir Tablets

    HEALTH CANADA

    Enforcement Report - Week of July 27, 2022

    FDA

    Enforcement Report - Week of May 25, 2022

    FDA

    Apotex Launches Affordable Generic Option to Treat Relapsing Remitting Multiple Sclerosis

    PRESS RELEASE

    Apotex`s Generic Dasatinib Receives Approval in the US

    FDA

    Product Donation Supports Clinical Study to Evaluate FDA-Approved Medications

    PRNEWSWIRE

    Canadian Cancer Patients Have New Affordable Treatment Option

    NEWSWIRE

    Apotex`s Generic Ceftaroline Fosamil Receives Approval In US

    FDA

    Apotex`s Gneneric Icosapent Ethyl Receives Approval In US

    FDA

    Enforcement Report - Week of April 14, 2021

    FDA

    Enforcement Report - Week of February 17, 2021

    FDA

    Apotex Corp. Issues Voluntary Nationwide Recall of Enoxaparin Sodium Injection

    FDA

    Enforcement Report - Week of June 24, 2020

    FDA

    Health Canada Issues Recall of Apotex Inc`s APO-Metformin

    HEALTH CANADA

    Apotex Corp. Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets 500mg Due to the Detection of N-nitrosodimethylamine (NDMA)

    FDA

    Apotex`s Generic Penicillamine Receive Approval in U.S

    FDA

    Enforcement Report - Week of November 20, 2019

    FDA

    Enforcement Report - Week of November 6, 2019

    FDA

    Apotex Corp. Issues Voluntary Nationwide Recall of Ranitidine Tablets 75mg and 150mg

    FDA

    Apotex`s Generic Doxycycline Hyclate Receives Approval in US

    FDA

    Apotex Corp. Issues Recalls of Drospirenone and Ethinyl Estradiol Tablets

    FDA

    TGA Issues Recall of Mylan Australia`s Dilart and Dilart HCT (valsartan)

    TGA

    Apotex Recalls Pantoprazole 40 mg tablets Due toThis Medicine May Have Been Dispensed With Missing Blister Sheets

    TGA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.